•
Sep 30, 2022
The Joint Q3 2022 Earnings Report
The Joint Corp. reported third quarter results with revenue growth and clinic expansion.
Key Takeaways
The Joint Corp. reported a 27% increase in revenue to $26.6 million and system-wide sales grew 18% to $110.4 million. The company opened 38 new clinics and surpassed the 800 clinic milestone, closing the quarter with 805 clinics.
Revenue increased by 27% compared to Q3 2021, reaching $26.6 million.
System-wide sales grew by 18% to $110.4 million.
The company opened 38 new clinics, exceeding the 800 clinic milestone.
Net income was $491,000, or $0.03 per diluted share.
The Joint
The Joint
Forward Guidance
Management modified financial guidance and reiterated guidance related to clinics for 2022.